Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Published data (STEP 4, JAMA 2022) show that most patients regain a portion of lost weight after discontinuation
The removal of tiered systems in the NICE NG246 guideline on overweight and obesity management (NICE, 2025) signals a shift towards reconsidering access routes and care models for obesity management beyond the previous stepwise tiered system
Semaglutide injections aid in weight management
It can help improve mood, reduce inflammation and pain, regulate appetite, and support sleep all of which are commonly disrupted in thyroid and autoimmune disorders
In a blinded study extension, 532 participants with a baseline BMI of at least 35, who had all tolerated their assigned dose in the initial study, received retatrutide at a maximum tolerated dose of either 9 or 12 mg up to 104 weeks
Frontiers in Endocrinology, 2026
US$ 27.53
US$ 29.64
US$ 29.20
US$ 21.30
